Fibrous dysplasia of bone is a rare condition where part of a bone develops with weaker, scar-like tissue instead of normal bone. Many living with fibrous dysplasia of bone are recognized in childhood or the teen years, though some are not found until adulthood. Common features include bone pain, a limp, repeated fractures, or a bone that slowly bends or enlarges, so early signs of fibrous dysplasia of bone can be easy to miss at first. Not everyone will have the same experience, but fibrous dysplasia of bone often lasts lifelong and may become more stable after puberty. It is usually managed with pain relief, monitoring, physical support, and sometimes surgery, and most people are not affected in life span unless the disease is severe or involves important areas such as the skull.
How many people live with Fibrous dysplasia of bone?
Based on widely cited estimates of about 1 in 15,000 to 1 in 30,000 people, fibrous dysplasia of bone may affect roughly 270,000 to 540,000 people worldwide (FD/MAS Alliance, 2024) and about 11,000 to 22,000 people in the United States (FD/MAS Alliance, 2024). These are rough estimates rather than direct counts, so the true number may be a little higher or lower.
Overview
Fibrous dysplasia of boneSymptoms
Fibrous dysplasia of bone can cause bone pain, limping, or repeated fractures. Many living with fibrous dysplasia of bone also have bone deformity, such as a curved leg or uneven face shape. Signs vary by which bones are affected.
Outlook and prognosis
Many people with fibrous dysplasia of bone live full lives, especially when the condition is mild and monitored over time. Outlook depends on how many bones are affected and whether pain, fractures, or bone changes interfere with daily activities.
Causes and risk factors
Fibrous dysplasia of bone is usually caused by a random change in the GNAS gene early before birth. It is not typically inherited. Lifestyle, diet, and environmental exposures are not known to cause fibrous dysplasia of bone.
Genetic influences
Genetics are central to fibrous dysplasia of bone. It is usually caused by a non-inherited change in the GNAS gene that happens early in development, so family members are rarely affected.
Diagnosis
Doctors diagnose fibrous dysplasia of bone using symptoms, an exam, and imaging, especially X-rays or CT scans. The diagnosis of fibrous dysplasia of bone is often confirmed by its typical imaging findings. A biopsy is sometimes needed.
Treatment and drugs
Fibrous dysplasia of bone is treated based on symptoms, bone strength, and which bones are affected. Pain-relieving medicines and drugs that help calm bone pain may be used. Some people need surgery to stabilize a bone, correct shape, or treat fractures.
Symptoms
Fibrous dysplasia of bone can affect daily life in very different ways, depending on which bone is involved and how much of it is affected. Many living with fibrous dysplasia of bone have only mild problems, while others notice pain, swelling, a limp, or bones that break more easily. The early features of fibrous dysplasia of bone may be subtle, such as an ache after activity or a gradual change in the shape of a leg or part of the face. Features vary from person to person and can change over time.
Some people have no noticeable day-to-day problems, and fibrous dysplasia of bone is found after an X-ray or scan done for another reason. This is more common when only a small area of one bone is involved.
A dull ache or tenderness can come and go, often with activity or after standing for a long time. For many people with fibrous dysplasia of bone, pain is the feature that first leads to medical care.
An affected bone may slowly widen, curve, or look uneven. This can show up as a change in the shape of a leg, ribs, jaw, or one side of the face.
Weakened bone can crack or break more easily than expected, sometimes after a minor fall, twist, or bump. Breaks are especially common in weight-bearing bones such as the thighbone or shin.
How people usually first notice Fibrous dysplasia of bone?
Fibrous dysplasia of bone is often first noticed when a child or teenager develops persistent bone pain, a limp, or a swelling over part of a bone that seems more prominent over time. For many living with fibrous dysplasia of bone, the first signs can also be a broken bone after a minor fall, a difference in leg length, or a curve in the spine that a parent, coach, or doctor picks up during growth. Sometimes there are no obvious symptoms at first, and the condition is first found by chance on an X-ray done for pain, injury, or another bone concern.
Types of Fibrous dysplasia of bone
Fibrous dysplasia of bone can affect daily life in different ways, from one painful weak spot in a bone to changes in several bones that make walking, sports, or even routine chores harder. In medical terms, the main variants of Fibrous dysplasia of bone are grouped by how many bones are involved and whether hormone or soft-tissue findings occur alongside the bone changes. Symptoms do not always look the same from one variant to another, and severity can range from mild to more limiting.
Monostotic
This is the most common variant, and it affects just one bone. Many people have few or no symptoms, while others notice pain, swelling, a limp, or a fracture after only minor strain. The ribs, thighbone, shinbone, skull, and upper arm are common sites.
Polyostotic
This variant affects more than one bone and often causes more noticeable symptoms than the single-bone form. Many living with Fibrous dysplasia of bone in this form have bone pain, repeated fractures, leg-length difference, or bending of the arms or legs that can affect walking. The early symptoms of Fibrous dysplasia of bone may start in childhood when several bones are involved.
McCune-Albright syndrome
This is a recognized syndrome in which fibrous dysplasia occurs together with hormone problems and café-au-lait skin patches. Bone disease is usually polyostotic and may be more extensive, so pain, deformity, and fractures can be more pronounced. Some may also have early puberty or other hormone-related symptoms, depending on which glands are affected.
Mazabraud syndrome
This uncommon variant combines fibrous dysplasia of bone with soft-tissue lumps called intramuscular myxomas. The bone symptoms are similar to other forms and can include pain, deformity, or fracture, while the soft-tissue lumps are often slow-growing and may or may not be painful. Doctors usually recognize this variant when both the bone changes and these muscle-area lumps are present.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicine can meaningfully delay fibrous dysplasia of bone from starting, because it usually begins from a gene change that happens early in development. Research has not shown that diet, exercise, vitamins, or supplements can prevent it, although not smoking, keeping up overall bone health, and staying safely active may still help lower the chance of fractures or worsening pain. Regular checkups can help find weak spots, breaks, or related hormone problems early and treat symptoms sooner, which can make day-to-day life easier even though it does not stop the condition itself.
What genetics can tell you about symptoms
Genetics can explain why fibrous dysplasia of bone develops, but it usually does not let doctors predict exactly which symptoms someone will have day to day. The condition is linked to a change in the GNAS gene that happens after conception, and the timing and location of that change in the body can affect which bones are involved, whether symptoms start in childhood or later, and how mild or severe problems like bone pain, fractures, or changes in bone shape may be. Even so, people with the same condition can have very different symptoms, so genetics gives part of the picture rather than a precise forecast.
Causes and risk factors
In fibrous dysplasia of bone, the main cause is a random change in the GNAS gene that happens after conception. This change is almost never inherited, so it usually does not run in families. How early the change happens can affect how much of the skeleton is involved. Risk can vary widely from person to person. Unlike many bone conditions, the usual risk factors for fibrous dysplasia of bone do not include diet, exercise, injuries, or everyday environmental exposures.
What are the most common causes or risk factors?
Fibrous dysplasia of bone is usually caused by a random change in a gene that affects how bone develops, and this change happens early in growth before birth. It is almost never inherited from a parent, and there are no well-proven lifestyle or environmental risk factors such as diet, exercise, or injury. In some people, the same gene change also affects other parts of the body, which can lead to a broader condition with hormone problems and skin color changes.
Environmental and biological risk factors
When people ask what causes fibrous dysplasia of bone, the short answer is that it usually begins with a random change in a few developing cells after conception. Researchers have not found clear links to common environmental exposures, and parents do not cause it by something they did or did not do. Awareness of both biological and environmental influences helps you feel prepared.
Fibrous dysplasia of bone usually starts with a chance change in developing cells that help form bone. It is generally not inherited and is not tied to a known outside exposure.
The earlier this change happens in development, the more areas of the body it can involve. If it happens later, it is more likely to stay limited to one bone or a small number of bones.
In some people, the same early cell change affects bone along with skin or hormone-making tissues. This points to a broader biological pattern rather than a separate environmental trigger.
No environmental factor has been clearly shown to raise the chance of fibrous dysplasia of bone. Doctors do not currently link it to routine injuries, infections, or everyday exposures in a reliable way.
Genetic risk factors
For many living with fibrous dysplasia of bone, one of the first questions is what caused it and whether relatives could develop it too. The genetic causes of fibrous dysplasia of bone usually involve a change in the GNAS gene that happens early after conception, rather than a gene change passed down through a family. Because the change appears in only some cells, the condition can affect one bone or many, and symptoms can vary widely. People with the same risk factor can have very different experiences.
GNAS change: Most cases begin with a change in the GNAS gene, which helps control how certain bone cells behave. When this signal is altered, normal bone can be replaced by softer, fibrous tissue that is more likely to bend, swell, or break.
After conception: The gene change usually happens after fertilization, during early development. This means fibrous dysplasia of bone is generally caused by a spontaneous change in the body’s cells, not by a gene variant inherited from a parent.
Mosaic pattern: Only some cells carry the genetic change, creating a patchwork, or mosaic, pattern in the body. If the change happens earlier in development, more bones may be involved; if it happens later, just one bone may be affected.
Family history: A common question is whether fibrous dysplasia of bone is inherited, and in most cases the answer is no. Having a family member with the condition usually does not raise your own genetic risk in the way it does with strongly inherited disorders.
Syndrome forms: In some people, the same GNAS change affects bone along with skin or hormone-producing glands. When that happens, fibrous dysplasia can be part of a broader condition, such as McCune-Albright syndrome, rather than a separate genetic cause.
Lifestyle risk factors
Fibrous dysplasia of bone is not caused by lifestyle habits, but daily choices can influence pain, fracture risk, mobility, and long-term bone health. When people ask about lifestyle risk factors for fibrous dysplasia of bone, the key issue is usually how lifestyle affects fibrous dysplasia of bone rather than what causes it. The most helpful focus is on habits that change mechanical stress on weakened bone, support muscle strength, and reduce factors that can worsen symptoms or complications.
High-impact sports, repetitive loading, and activities with a high fall risk can increase pain or raise the chance of stress injury in affected bone. Lower-impact exercise choices may help preserve fitness while reducing excess strain on fragile areas.
Weak muscles can place more stress on abnormal bone and may worsen instability around involved limbs. Guided strengthening and balance work can improve joint support, walking efficiency, and confidence with movement.
Excess body weight increases mechanical load on weight-bearing bones affected by fibrous dysplasia and may make pain or mobility problems worse. A steady, healthy weight can reduce stress on the hips, legs, and spine.
Poor intake of calcium or vitamin D does not cause fibrous dysplasia, but it can undermine overall bone health and make it harder to support unaffected bone. Meeting recommended intake may help maintain skeletal strength as part of broader care.
Risk prevention
Fibrous dysplasia of bone usually cannot be prevented, because it happens from a gene change that develops early in growth and is not something you cause. For many living with fibrous dysplasia of bone, prevention is mainly about lowering the chance of fractures, worsening bone pain, and deformity, while protecting day-to-day movement and function. Prevention is about lowering risk, not eliminating it completely.
Ongoing care with an orthopedic doctor or other specialist can help track fibrous dysplasia of bone before problems become more serious. Checkups and imaging are often used to watch for bone weakening, changes in shape, or areas at higher risk of fracture.
Heavy contact sports, repetitive jumping, or other high-impact activities can raise the chance of pain or a broken bone in weakened areas. Safer movement plans can often be tailored so you stay active without putting too much stress on affected bone.
Physical therapy and muscle-strengthening work can improve balance, joint support, and everyday mobility. This may help reduce falls and make walking, climbing stairs, or getting up from a chair feel steadier.
Simple steps at home and outdoors can lower the risk of injury when fibrous dysplasia affects the legs, hips, or spine. Good footwear, clear walking paths, handrails, and attention to dizziness or poor vision can all help.
Can you prevent Fibrous dysplasia of bone?
No, fibrous dysplasia of bone cannot usually be prevented because it is linked to a random change in a gene that happens early in development, not to anything you or your parents did. There is also no proven lifestyle change that can stop it from starting, although early care may help lower the risk of problems such as pain, bone weakness, or broken bones.
Transmission
If you or your child has fibrous dysplasia of bone, it can be reassuring to know that this condition is not contagious and does not spread from one person to another. When people ask about how fibrous dysplasia of bone is inherited, the answer is that it usually is not passed down in families.
Fibrous dysplasia of bone is most often caused by a random gene change that happens very early after conception, while the body is still developing. Because that change is usually not present in the egg or sperm, parents do not typically pass fibrous dysplasia of bone to their children, and most people living with it have no family history of the condition.
When to test your genes
For fibrous dysplasia of bone, routine gene testing is usually not needed for early detection because it is typically caused by a non-inherited GNAS change that happens after conception. Testing may help when the diagnosis is unclear, especially in atypical cases, and it often works best on affected bone tissue rather than blood.
Diagnosis
Fibrous dysplasia of bone is often found after ongoing bone pain, a limp, repeated fractures, or a bone that slowly changes shape. In many living with fibrous dysplasia of bone, the first clues come from an X-ray done after an injury or for another reason. The diagnosis of fibrous dysplasia usually combines symptoms, imaging findings, and sometimes a small tissue sample when the picture is not fully clear.
Doctors ask about bone pain, fractures, limping, and any change in bone shape over time. A detailed family and health history can help show whether one bone or several bones may be involved.
The exam looks for tenderness, swelling, differences in limb length, or visible bending of a bone. Doctors also check how well nearby joints move and whether walking or balance has been affected.
Standard X-rays are often the first imaging test and may show the typical hazy or ground-glass look seen in fibrous dysplasia of bone. They can also show thinning, expansion, or bowing of the bone and help spot fractures.
CT scans give a more detailed view of bone structure, especially in the skull, face, spine, or pelvis. MRI is sometimes used to look at nearby soft tissues or to help rule out other causes when symptoms are less typical.
How is Fibrous dysplasia of bone diagnosed?
Fibrous dysplasia of bone is usually diagnosed from a mix of symptoms, a physical exam, and imaging tests such as X-rays, and sometimes CT or MRI scans, which can show the typical changes in the bone. If the picture is not clear, doctors may do a bone scan to see whether more than one bone is involved or take a small sample of bone to look at under a microscope. Genetic testing is not usually needed, but in some cases testing the affected bone for a gene change linked to this condition can help support the diagnosis.
Stages of Fibrous dysplasia of bone
Fibrous dysplasia of bone does not have defined progression stages. That is because it is not usually tracked as a step-by-step disease that moves through clear phases; instead, symptoms can vary by which bone is affected, how large the area is, and whether changes happen during growth. Doctors usually start with a conversation about pain, swelling, limping, or fractures, since early symptoms of fibrous dysplasia of bone can be mild and easy to overlook. Diagnosis and follow-up usually rely on imaging such as X-rays, sometimes with CT or MRI scans, and blood tests or a biopsy may be used if the findings are unclear.
Outlook and prognosis
The outlook for fibrous dysplasia of bone is usually good, especially when only one bone is affected, and many people have a normal life expectancy. Prognosis depends on how many bones are involved, whether lesions are near weight-bearing bones or the skull, and whether there are associated hormonal problems such as in McCune-Albright syndrome. Some patients remain stable for years, while others develop pain, fractures, deformity, limb-length differences, or nerve compression that may require ongoing monitoring and treatment. Malignant transformation is rare, generally estimated at well under 1% in most series, but the risk is higher in previously irradiated lesions, so radiation therapy is usually avoided. Mortality is uncommon in isolated disease and is more likely to relate to severe complications in extensive polyostotic disease, such as major skeletal burden, craniofacial involvement, or complications of associated endocrine disorders.
Long-term effects
Fibrous dysplasia of bone can have lasting effects on how bones grow, bear weight, and heal over time. Many living with fibrous dysplasia of bone may have only one area involved, while others have several bones affected and a broader long-term picture. Long-term effects vary widely, and they often depend on which bones are involved, how much bone is affected, and whether hormone-related problems are also present.
Ongoing aching or deep bone pain can continue for years, especially in weight-bearing bones such as the hip, thigh, or lower leg. For many, this can mean pain with long walks, standing for long periods, or after minor strain.
Weakened bone can break more easily than usual, sometimes after a small fall or even routine activity. Repeated stress can also lead to tiny cracks in the bone, which may be part of the early symptoms of fibrous dysplasia of bone and can remain a long-term problem.
Affected bones may slowly bend, enlarge, or become misshapen over time. In children, this can become more noticeable during growth, and in adults the change may then remain stable or progress more slowly.
When fibrous dysplasia affects the legs, hips, or pelvis, it can change alignment and place uneven stress on joints. Some may find that limping, leg length differences, or reduced stamina become ongoing issues in daily life.
How is it to live with Fibrous dysplasia of bone?
Living with fibrous dysplasia of bone can be very different from one person to the next: some people have only mild symptoms, while others deal with ongoing bone pain, a limp, repeated fractures, or changes in bone shape that make walking, sports, work, or even long days on their feet more tiring. When the skull or face is involved, it can also affect appearance and sometimes hearing, vision, or dental care, which can add emotional stress as well as physical challenges. For families and other close supporters, this often means helping with appointments, pain flare-ups, activity limits, and recovery after procedures, but with good medical follow-up and practical support, many people with fibrous dysplasia find ways to stay active and build daily routines that work for them.
Treatment and drugs
Fibrous dysplasia of bone is treated based on which bones are affected, how much pain or weakness it causes, and whether it is leading to fractures, deformity, or pressure on nearby nerves. Many living with fibrous dysplasia of bone do well with regular follow-up, pain relief, physical therapy, and activity changes to protect the bone while staying as active as possible. Doctors sometimes recommend a combination of lifestyle changes and drugs, especially medicines to ease bone pain, and some people may also need vitamin D or calcium if levels are low. If a bone is badly weakened, repeatedly breaks, or is changing shape, surgery may be used to stabilize it, correct alignment, or reduce pressure on nearby structures. Finding the right therapy can take some time, because treatment is guided by symptoms, age, and which bones are involved rather than one single plan for everyone.
Can you cure Fibrous dysplasia of bone?
No, there is no cure for fibrous dysplasia of bone at this time. Treatment can still help by easing pain, lowering the chance of broken bones, and supporting or repairing bones that have become weak, misshapen, or more likely to fracture; this may include pain relief, monitoring, and sometimes surgery. Many people living with fibrous dysplasia of bone can manage it well with ongoing care, although treatment needs can vary depending on which bones are affected.
Non-drug treatment
Living with fibrous dysplasia of bone can mean ongoing bone pain, limping, or limits on sports, work, and daily movement. Managing this condition often involves easing strain on the affected bone, protecting strength and balance, and watching for changes over time rather than relying only on medicine. Non-drug treatments for fibrous dysplasia of bone are chosen based on which bones are involved, how severe the symptoms are, and whether there is bending, fracture risk, or pressure on nearby nerves. Some people need only regular follow-up, while others benefit from therapy, supports, or surgery.
Regular checkups and imaging help track pain, bone shape, and whether a lesion is growing or becoming weaker. This is especially important in children and teens, when bones are still developing.
Physical therapy can improve strength, joint motion, posture, and walking mechanics when fibrous dysplasia of bone affects the legs, hips, or spine. Some may find that targeted exercises reduce strain on nearby muscles and make daily movement easier.
Lower-impact exercise and avoiding repeated high-force loading can help protect a weakened bone. Not every approach works the same way, so activity plans are usually tailored to pain, location, and fracture risk.
Braces, shoe inserts, or other supports may improve alignment and reduce stress on painful or bowed bones. For many, treatment begins not at the pharmacy, but with simple measures that make standing and walking feel steadier.
Your genes may have an impact on how drugs work for you
For people living with fibrous dysplasia of bone, the gene change that causes the condition usually does not help doctors predict which common medicines will work best or cause side effects, so genetic testing is not routinely used to choose treatment. In day-to-day care, response to pain relievers or medicines used to help with bone pain can vary from person to person, but this is usually judged by symptoms, side effects, age, and which bones are affected rather than by inherited differences in how the body handles drugs. In other words, even though this condition is genetic, there is not a well-established role for using genetics to tailor its usual medicines at this time.
Pharmacological treatments
Treatment is mainly aimed at easing pain and lowering the risk of problems such as repeated fractures, rather than removing fibrous dysplasia of bone itself. When people ask about medications for fibrous dysplasia of bone pain, the answer usually starts with pain relievers and, in some cases, bone-targeting drugs. Not everyone responds to the same medication in the same way. The choice depends on how severe symptoms are, which bones are affected, and whether related hormone problems are also present.
Acetaminophen and nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen are often used first for mild to moderate bone pain. They can help with day-to-day discomfort, like pain after walking, standing a long time, or a minor bump.
Pamidronate and zoledronic acid are the main bone-targeting drugs used for people with fibrous dysplasia of bone who have ongoing pain or active bone lesions. These medicines may reduce bone pain in some people, although they do not reliably shrink the lesions or cure the condition.
Alendronate is sometimes tried when a bisphosphonate is considered, but the benefit for pain in fibrous dysplasia of bone has been inconsistent. Because of that, many specialists prefer intravenous options when this drug class is used.
Denosumab has been used in selected severe or hard-to-treat cases, usually by specialists with close monitoring. It can lower bone turnover, but pain can return after stopping it and calcium levels may shift, so it is not routine first-line treatment.
Genetic influences
People living with fibrous dysplasia of bone often want to know whether it started in their genes, especially if pain, limping, or a fracture has disrupted everyday life. A change in a gene can sometimes affect health, and in fibrous dysplasia of bone the usual change involves a gene called GNAS. This change happens early after conception rather than being inherited from a parent, so fibrous dysplasia of bone usually does not run in families in the usual way. Because only some cells carry the change, some may have just one affected bone while others have several, and a few also develop hormone or skin changes as part of a related condition called McCune-Albright syndrome. This timing also helps explain why blood tests may miss the gene change, and why testing of affected tissue is sometimes more useful. For most families, the key point is that fibrous dysplasia of bone is genetic in origin but is not typically something parents pass down to their children.
Is Fibrous dysplasia of bone genetic?
Genetics are central to fibrous dysplasia of bone. It is usually caused by a non-inherited change in the GNAS gene that happens early in development, so family members are rarely affected.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant linked with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors play a part. In some situations, though, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Bone pain, a limp, or repeat fractures can make treatment decisions feel very personal for people with fibrous dysplasia of bone. The main genetic change behind fibrous dysplasia of bone usually happens after conception, often in a gene called GNAS, so it affects only some bones or tissues and is usually not inherited. That gene change can help confirm the diagnosis and may partly explain why one person has a small, quiet area of disease while another has more widespread bone involvement or related hormone problems. In everyday care, though, the best treatment for fibrous dysplasia of bone is still chosen mostly by symptoms and imaging findings, not by a test that predicts medication response; doctors may use pain relievers, sometimes bisphosphonates for bone pain, and surgery when a bone is weak or misshapen. Not every difference in response is genetic, but there is currently no widely used pharmacogenetic test that can reliably tell doctors which common medicine will work best for this condition. Researchers are studying treatments that target the overactive signaling caused by GNAS, but for now care focuses on easing pain, lowering fracture risk, and treating any related hormone disorders.
Interactions with other conditions
Fibrous dysplasia of bone can sometimes occur on its own, but for some people it is part of a broader health picture that affects more than just the bones. Doctors call it a comorbidity when two conditions occur together. In some people living with fibrous dysplasia of bone, hormone-related problems such as early puberty, an overactive thyroid, or too much growth hormone can happen alongside it, especially in a rare condition called McCune-Albright syndrome. These added conditions may increase bone pain, raise the chance of fractures, or make bone changes progress more quickly, so care often needs input from both bone and hormone specialists. A less common overlap is with soft-tissue lumps called intramuscular myxomas, which can occur in a condition known as Mazabraud syndrome. If you are dealing with fibrous dysplasia of bone and endocrine disorders, regular follow-up can help doctors spot changes early and adjust treatment to protect bone strength and day-to-day function.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Fibrous dysplasia of bone?
Other problems that can look like fibrous dysplasia of bone include bone cysts, non-cancerous bone growths, Paget disease, which is a condition that disrupts normal bone rebuilding, and areas of bone damage from an old injury or infection. In some cases, doctors also need to rule out rarer but more serious causes such as bone cancer, especially if pain or swelling is getting worse quickly or the bone breaks more easily than expected.
History
People living with fibrous dysplasia of bone often spend years trying to make sense of pain, limping, or a bone that breaks more easily than expected. Long before modern scans existed, doctors could see that some bone conditions behaved differently from infections or cancer, but they did not yet have clear names or categories for them.
In the late 1930s, researchers began describing fibrous dysplasia of bone as a distinct disorder rather than grouping it with other bone growth problems. Early reports were based on what surgeons and pathologists saw: normal hard bone had been partly replaced by softer, fibrous tissue, which could leave the bone weaker or misshapen. At first, this was understood mainly through symptoms, X-rays, and tissue samples, because there were no genetic tests or advanced imaging tools to explain why it happened.
As medical science evolved, doctors also recognized that fibrous dysplasia of bone does not look the same in everyone. Some people have one affected bone, while others have many, and a smaller group have fibrous dysplasia as part of a broader syndrome that can also affect hormones and skin pigmentation. This mattered in everyday care: a child with a new limp and repeated fractures might once have been thought to have a different bone disease altogether, while an adult with long-standing bone pain might have gone years without a clear diagnosis.
By the second half of the 20th century, better X-rays, CT scans, and bone imaging made it easier to tell fibrous dysplasia from other causes of bone pain or swelling. Doctors also learned more about how the condition changes over time, including the fact that many areas grow during childhood and adolescence, then often become more stable in adulthood. That history still shapes care today, especially when doctors explain the early symptoms of fibrous dysplasia of bone and decide whether monitoring, pain treatment, or surgery is most helpful.
In recent decades, awareness has grown, and researchers later identified a genetic cause, which helped confirm that fibrous dysplasia of bone is a developmental bone disorder rather than something contagious or a typical inherited disease passed through families in the usual way. Looking back helps explain why diagnosis is often clearer now than it was in the past, even though many living with fibrous dysplasia still need care from more than one specialist over time.